We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Humana Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)
Price data last checked 91 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes. The authors focus on the extrinsic system of death receptors, their regulation and function, and their abnormalities in cancer. Topics of particular interest include resistance to apoptosis, TRAIL signaling, death receptors in embryonic development, mechanisms of caspase activation, and death receptor mutations in cancer. Additional chapters address death signaling in melanoma, synthetic retinoids and death receptors, the role of p53 in death receptor regulation, immune suppression of cancer, and combination therapy with death ligands.
Key Features
Used Book in Good Condition
Product Specifications
- Brand
- Humana
- Format
- hardcover
- ASIN
- 1588291723
- Domain
- Amazon UK
- Release Date
- 03 December 2004
- Listed Since
- 05 February 2007
Barcode
No barcode data available
Similar Products You Might Like
95% match
Cell Death Signaling in Cancer Biology and Treatment (Cell Death in Biology and Diseases)
Humana
£80.09
02 Apr 2026
94% match
Death Receptors and Cognate Ligands in Cancer: 49 (Results and Problems in Cell Differentiation, 49)
Springer
£143.56
21 Jan 2026
93% match
Death Receptors and Cognate Ligands in Cancer: 49 (Results and Problems in Cell Differentiation, 49)
Springer
£139.23
13 Jan 2026
93% match
Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)
Humana
£84.34
23 Feb 2026
93% match
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
Humana
£149.75
13 Jan 2026
93% match
Cancer Drug Resistance (Cancer Drug Discovery and Development)
Humana
£35.15
13 Jan 2026
93% match
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
Humana
£80.09
28 Feb 2026
93% match
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
£144.18
08 Mar 2026
93% match
EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
£155.47
28 Jan 2026
93% match
Humana DNA Repair in Cancer Therapy - Drug Discovery Book
Humana
£33.25
05 Mar 2026
93% match
Cancer Drug Resistance (Cancer Drug Discovery and Development)
Humana
£154.49
13 Jan 2026
93% match
Humana Combination Cancer Therapy: Modulators and Potentiators
Humana
£34.76
18 Apr 2026
93% match
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
Humana
£109.28
05 Mar 2026
92% match
Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
£31.32
18 Mar 2026
92% match
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
Humana
£147.91
10 Mar 2026
92% match
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
Humana
£117.40
15 Jan 2026
92% match
Advances in Cancer Signal Transduction and Therapy
Bentham Science Publishers
£82.52
09 Apr 2026
92% match
EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
£44.40
02 Mar 2026
92% match
Humana - T Cell Based Cancer Immunotherapies Book
Humana
£108.15
03 Mar 2026
92% match
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
Humana
£112.39
31 Jan 2026
92% match
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
Humana
£80.39
07 Apr 2026
92% match
Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)
Humana
£84.08
18 Feb 2026
92% match
Targeted Therapeutics in Melanoma (Current Clinical Oncology)
Humana
£80.27
19 Apr 2026
92% match
Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases
Springer
£108.78
06 Mar 2026